The role of innovation in drug development

被引：116
|
作者：
Drews, J [1 ]
Ryser, S [1 ]
机构：
[1] HOFFMANN LA ROCHE AG,INT RES STAFF,CH-4002 BASEL,SWITZERLAND
来源：
NATURE BIOTECHNOLOGY | 1997年 / 15卷 / 13期
关键词：
D O I：
10.1038/nbt1297-1318
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1318 / 1319
页数：2
相关论文
共 50 条
  • [1] Drug Development: The role of innovation in drug development
    Jürgen Drews
    Stefan Ryser
    Nature Biotechnology, 1997, 15 : 1318 - 1319
  • [2] The Role of Funding and Policies on Innovation in Cancer Drug Development
    Kanavos, P.
    Sullivan, R.
    Lewison, G.
    Schurer, W.
    Eckhouse, S.
    Vlachopioti, Z.
    ECANCERMEDICALSCIENCE, 2010, 4 : 1 - 139
  • [3] Innovation in drug development
    Szelejewski, Wieslaw
    Kutner, Andrzej
    PRZEMYSL CHEMICZNY, 2012, 91 (03): : 255 - 262
  • [4] Innovation in Drug Development
    Vogenberg, F. Randy
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (02): : 69 - 69
  • [5] Innovation in Oncology Drug Development
    Huber, Matthew
    Huber, Brian
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [6] Rewarding Innovation in Drug Development
    Saadi, Emily
    White, Greg
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (07): : 373 - 374
  • [7] The state of innovation in drug development
    Kola, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 227 - 230
  • [8] Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development
    Pariser, Anne R.
    Gahl, William A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S804 - S807
  • [9] Important Role of Translational Science in Rare Disease Innovation, Discovery, and Drug Development
    Anne R. Pariser
    William A. Gahl
    Journal of General Internal Medicine, 2014, 29 : 804 - 807
  • [10] The enabling role of the public sector in innovation: A case study of drug development in India
    Mehra, Kavita
    Joshi, Kirti
    INNOVATION-ORGANIZATION & MANAGEMENT, 2010, 12 (02): : 227 - 237
12345